United States
AT
AU
BE
CA
CH
CN
CZ
DE
DK
ES
FI
FR
GR
HR
HU
IE
IL
IN
IT
JP
NL
NO
PL
PT
RO
RU
SE
SK
TR
UK
ZA
Menu
Alert: Product and Recall NoticesAndroid is a trademark of Google LLC.
"Google Play" is a property of Google LLC.
AppStore® online store is a service mark of Apple Inc.
Not sure about your phone model?
Identify your iPhone®† mobile digital device model number
Identify your Samsung®§ mobile device model number
Frequently asked questions
To identify the model number of your device, see below:
- Settings > About Phone
Note: Android™ phone devices (e.g., Samsung Galaxy 10) have multiple model numbers, which indicate details specific to the device. These model numbers are listed above in parenthesis (e.g. SM-G973F). Only Android phone device model numbers listed in the table above are compatible with the MiniMed™ 770G system. The device model number can be found by navigating to the phone’s settings, opening device settings, and then by tapping “About phone.”
To identify the model number of your device, see below:
- Settings > General > About
You can still use the MiniMed™ 780G system as the pump, transmitter, and meter have full functionality without internet access. Without a compatible smartphone, individuals will not have access to the apps which provide additional ways to view glucose and insulin delivery trends. In order to have care partners follow data, the individual using the MiniMed™ 780G system must have their own compatible smartphone. If a customer does not have their own smartphone, there is a blue adapter that can be used to upload data both at home and at HCP offices. There are some options we can discuss with you today if you need to get started on therapy right away. Feel free to give us a call at 800-646-4633. Our call center is open weekdays from 9AM-6PM CT.
Turning off Automatic Updates on your mobile device may help you avoid unintentionally updating to an operating system that is not confirmed as compatible with the MiniMed™ 780G system mobile apps.
The MiniMed™ 780G system is a medical device and we do extensive testing on all updates. You may experience a delay from when Apple or Android™ releases a new operating system / device model and when the mobile apps are compatible. Before updating your operating system or device, check the compatibility list above.
From the settings menu, go to General, go to Software Updates and set Automatic Updates to the “off” position.
From the System updates menu, select Automatic security updates and turn OFF.
† iPhone® mobile digital device is a registered trademark of Apple Inc.
§ Samsung® is a registered trademark of Samsung.
∆ Smart devices sold separately. For a list of compatible devices, refer to user guide.
The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed™ 780G system consists of the following devices: MiniMed™ 780G insulin pump, the Guardian™ 4 transmitter, the Guardian™ 4 sensor, One-press serter, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™ Guide test strips. The system requires a prescription from a healthcare professional.
The Guardian™ 4 sensor is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian™ 4 sensor is indicated for up to seven days of continuous use.
The Guardian™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ 4 sensor. The Guardian™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.
WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.
WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library
MiniMed™ 780G system with SmartGuard™ technology with Guardian™ Sensor (3)
The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G System includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed™ 780G System consists of the following devices: MiniMed™ 780G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), One-press serter, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™ Guide Test Strips. The system requires a prescription from a healthcare professional.
The Guardian™ Sensor (3) is intended for use with the MiniMed™ 780G system and the Guardian™ Link (3) transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian™ (3) sensor is indicated for seven days of continuous use.
The Guardian™ Sensor (3) is not intended to be used directly to make therapy adjustment while the MiniMed™ 780G system is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3). The Guardian™ Sensor (3) is indicated for abdomen and buttock insertion for users ages 7-13 years, and abdomen and arm insertion for user ages 14 years and older.
WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.
WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with the system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library
Important Safety Information: MiniMed™ 770G System With SmartGuard™ Technology
The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the AccuChek®Guide Test Strips. The system requires a prescription.
The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).
All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.
WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.
WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safetyinformation#minimed-770g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library
Important Safety Information: MiniMed™ Mobile app
The MiniMed™ Mobile app is intended to provide a secondary display for a compatible MiniMed™ insulin pump system on a suitable consumer electronic device for passive monitoring and to sync data to CareLink™ system. The MiniMed™ Mobile app is not intended to replace the real-time display of Continuous glucose monitoring or insulin pump data on the primary display device (i.e., the insulin pump). All therapy decisions should be based on the primary display device. The MiniMed™ Mobile app is not intended to analyze or modify the continuous glucose monitoring data or insulin pump data that it receives. Nor is it intended to control any function of the connected continuous glucose monitoring system or insulin pump. The MiniMed™ Mobile app is not intended to receive information directly from the sensor or transmitter of a continuous glucose monitoring system.
Important Safety Information: CareLink™ Connect app
The CareLink™ Connect app is intended to provide a secondary display of insulin pump and CGM (Continuous Glucose Monitor) data on a supported mobile device. CareLink™ Connect app is not intended to replace the real-time display of insulin pump or CGM data on the primary display device. All therapy decisions should be based on the primary display device. CareLink™ Connect app is not intended to analyze or modify the insulin pump and CGM data that it receives. Nor is it intended to control any function of the insulin pump or CGM system to which it is connected. CareLink™ Connect app is not intended to receive information directly from the insulin pump or CGM system.
Important Safety Information: Guardian™ Connect app
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.
Important Safety Information: Medtronic Diabetes Updater app
The Medtronic Diabetes Updater app is intended for use on a suitable consumer electronic device to wirelessly update software of a MiniMed™ insulin pump with smart device connectivity. The Medtronic Diabetes Updater app is not intended to analyze or modify the continuous glucose monitor data or insulin pump data, nor is it intended to control any function of the connected continuous glucose monitoring system or insulin pump. The Medtronic Diabetes Updater app is not intended to receive information directly from the sensor or transmitter of a continuous glucose monitoring system. The Medtronic Diabetes Updater app is not intended to be used without a CareLink™ account. Log into an existing CareLink™ account or create a new account during the update process.